Financials data is unavailable for this security.
View more
Year on year Zhende Medical Co Ltd 's revenues fell -32.76% from 6.14bn to 4.13bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 681.13m to 198.40m, a -70.87% decrease.
| Gross margin | 34.16% |
|---|---|
| Net profit margin | 5.49% |
| Operating margin | 7.18% |
| Return on assets | 2.85% |
|---|---|
| Return on equity | 3.71% |
| Return on investment | 3.61% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Zhende Medical Co Ltd fell by 1.02bn. However, the company earned 452.11m from its operations for a Cash Flow Margin of 10.95%. In addition the company used 1.06bn on investing activities and also paid 423.28m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 20.95 |
|---|---|
| Tangible book value per share | 15.33 |
More ▼
Balance sheet in CNYView more
| Current ratio | 2.45 |
|---|---|
| Quick ratio | 1.80 |
| Total debt/total equity | 0.1794 |
|---|---|
| Total debt/total capital | 0.1465 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share increased 66.67% while earnings per share excluding extraordinary items fell by -73.92%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 2.71% |
|---|---|
| Div growth rate (5 year) | 47.58% |
| Payout ratio (TTM) | 64.55% |
| EPS growth(5 years) | 0.6507 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -60.80 |
More ▼
